On the evening of Monday, May 23, 2016 a fundraiser sponsored by co-founder Jeff Gitterman was held in honor of the Child Health Institute of New Jersey.
As part of Rutgers University’s leading comprehensive medical program and the Robert Wood Johnson Medical School, the Child Health Institute is dedicated to improving the health of children of all ages through the comprehensive biomedical research of mechanisms underlying children’s diseases. Jeff is an avid supporter of the Institute and sits on the Board of Directors.
About the Child Health Institute of New Jersey (CHINJ):
The Institute is the cornerstone of the children’s academic health campus in New Brunswick and collaborates in its research initiatives with Rutgers Robert Wood Johnson Medical School’s Department of Pediatrics and Pediatric Clinical Research Center, The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital and PSE&G Children’s Specialized Hospital. Together, they form a unique partnership of world-class institutions representing an exciting opportunity for the translation of research findings into improved pediatric care.
There are four major areas of research at Child Health Institute:
Inflammatory, immune and infectious diseases of childhood: Researchers are collaborating with pediatricians at the medical school to investigate autoimmune disorders, asthma and type 1 diabetes. The team is working to establish two multidisciplinary centers: the Center for Asthma Research and the Center for Type 1 Diabetes. Institute investigators also collaborate with pediatric rheumatologists investigating diseases such as pediatric lupus and juvenile idiopathic arthritis.
Neurodevelopment and autism: The Institute has recruited outstanding scientists who work with colleagues across Robert Wood Johnson Medical School and Rutgers, as well as with clinicians at PSE&G Children’s Specialized Hospital, to study the causes and treatments of autism and other neurodevelopmental disorders. The high rates of autism in New Jersey lend urgency to this research.
Pediatric cancers and stem cells: Institute investigators are working with scientists at Rutgers Cancer Institute of New Jersey to understand how pediatric cancers, including leukemia, arise from mutated tissue stem cells. They are also studying how adult stem cells may be used as novel therapies in regenerative and reparative medicine.
Childhood obesity and metabolism: In collaboration with pediatricians and scientists at the Rutgers Robert Wood Johnson Medical School and across Rutgers, Institute investigators are studying the neurological, genetic, environmental and inflammatory causes of obesity and its consequences for the long term.